Jinling Pharmaceutical Company Limited (000919.SZ)

CNY 6.91

(-1.14%)

Market Cap (In CNY)

4.26 Billion

Revenue (In CNY)

2.78 Billion

Net Income (In CNY)

99.65 Million

Avg. Volume

7.63 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
5.38-8.24
PE
50.54
EPS
0.13
Beta Value
0.481
ISIN
CNE0000010W5
CUSIP
-
CIK
-
Shares
621925000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Yang Wang
Employee Count
-
Website
https://www.jlyy000919.com
Ipo Date
1999-11-18
Details
Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products in China. The company offers Mailuoning injection for the treatment of thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, cerebral thrombosis and sequelae, multiple arteritis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, thrombophlebitis, etc.; ferrous succinate tablets for the prevention and treatment of iron deficiency anemia; and lentinan injection for treatment of malignant tumors. It also provides medical health care services. Jinling Pharmaceutical Company Limited is based in Nanjing, China.